Depakine Chrono Tab. 500mg

Ingredient

Sodium Valproate/Valproic Acid

Content

500mg

Indication

1) Prevention and treatment of epilepsy (absence seizure, tonic-clonic seizure, clonic seizures, psychomotor seizure, and mixed seizure) and personality disorder or behavioral disorder followed by epilepsy
2) Treatment of manic episodes associated with bipolar disorder
-In regard to manic episodes, safety and efficacy of this drug are not established for long-term use of 3 weeks or more. Therefore, a regular drug re-evaluation is needed for long-term drug use.

Dermatop Ointment/Cream/Soln. 0.25%

Ingredient

Prednicarbate

Content

2.5mg/g (Ointment and Cream), 0.25mg/100g (Solution)

Indication

Treatment of corticosteroid reactive dermatoses: Eczema, dermatitis (atopic dermatitis, seborrheic dermatitis, allergic contact dermatitis, parapsoriasis, lichen planus, prurigo), and psoriasis

Esperson Gel 0.05%

Ingredient

Desoxymethasone

Content

0.5mg/g

Indication

Treatment of corticosteroid reactive dermatoses: Contact dermatitis, nummular eczema, lichen simplex chronicus (neurodermatitis), discoid erythema, atopic dermatitis, seborrheic dermatitis, psoriasis, insect bites, acute vesiculobullous hand eczema, prurigo, and intertrigo

Esperson Lotion 0.25%

Ingredient

Desoxymethasone

Content

2.5mg/g

Indication

Treatment of corticosteroid reactive dermatoses: Contact dermatitis, nummular eczema, lichen simplex chronicus (neurodermatitis), discoid erythema, atopic dermatitis, seborrheic dermatitis, psoriasis, insect bites, acute vesiculobullous hand eczema, prurigo, and intertrigo

Fraxiparine Inj. (Pre-filled)

Ingredient

Nadroparin Calcium

Content

2850IU/0.3ml, 5700IU/0.6ml

Indication

1) Prophylaxis of thromboembolism, especially the prophylaxis of thromboembolism accompanying orthopedic surgery and general surgery
2) Treatment of deep vein thrombosis (DVT)
3) Prevention of clotting in extracorporeal circulation during hemodialysis
4) Treatment of unstable angina and non-Q wave myocardial infarction

Galafold Cap.

Ingredient

Migalastat Hydrochloride

Content

150mg (123mg as Migalastat)

Indication

Long-term treatment of patients aged 12 years and older with a confirmed diagnosis of Fabry disease (α-galactosidase A deficiency) and who have an amenable mutation

IMOJEV® Japanese encephalitis vaccine (live, attenuated)

Ingredient

Live, attenuated, recombinant Japanese encephalitis virus*: 4.0 – 5.8 log PFU

Content

Indication

prophylaxis of Japanese encephalitis caused by the Japanese
encephalitis virus, in persons from 9 months of age and over.

Ketas Cap. 10mg

Ingredient

Ibudilast Granule

Content

190mg (10mg as Ibudilast)

Indication

Treatment of post stroke dizziness in patients with chronic cerebral circulation disorder associated with a previous cerebral infarction

Lasix Inj.

Ingredient

Furosemide

Content

20mg/2ml

Indication

1) Management of edema associated with heart failure (i.e. congestive heart failure), cirrhosis of the liver (i.e. ascites), or renal disease; acute pulmonary edema
2) Management of essential or renal hypertension

Lasix Tab.

Ingredient

Furosemide

Content

40mg

Indication

Treatment of essential or renal hypertension; cardiac (congestive heart failure), renal, hepatic (ascites) and peripheral vascular edema